{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:38:17Z","timestamp":1787207897227,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1093\/humrep\/dei221","type":"journal-article","created":{"date-parts":[[2005,8,6]],"date-time":"2005-08-06T00:31:00Z","timestamp":1123288260000},"page":"3328-3332","source":"Crossref","is-referenced-by-count":53,"title":["Metabolic syndrome in young Czech women with polycystic ovary syndrome"],"prefix":"10.1093","volume":"20","author":[{"given":"J.","family":"Vrbi\u0301kova\u0301","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Vondra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cibula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dvor\u030ca\u0301kova\u0301","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stanicka\u0301","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"S\u030cra\u0301mkova\u0301","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"S\u030cindelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bendlova\u0301","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"S\u030ckrha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,5]]},"reference":[{"key":"key\n\t\t\t\t20171012104259_DC-1997","doi-asserted-by":"crossref","unstructured":"(1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care20,1183\u20131197.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"key\n\t\t\t\t20171012104259_NCEP-2001","doi-asserted-by":"crossref","unstructured":"(2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA285,2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"key\n\t\t\t\t20171012104259_PCOS-2004","doi-asserted-by":"crossref","unstructured":"(2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod19,41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"key\n\t\t\t\t20171012104259_ADAMS-TAYLOR-2005","doi-asserted-by":"crossref","unstructured":"Adams JM , Taylor AE, Crowley WF Jr and Hall JE (2005) Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. Obstet Gynecol Surv60,239\u2013240.","DOI":"10.1097\/01.ogx.0000158501.52892.a0"},{"key":"key\n\t\t\t\t20171012104259_ALBERTI-AND-ZIMMER-1998","doi-asserted-by":"crossref","unstructured":"Alberti KG and Zimmer PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 15,539\u2013553.","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"key\n\t\t\t\t20171012104259_APRIDONIDZE-ESSAH-2005","doi-asserted-by":"crossref","unstructured":"Apridonidze T , Essah PA, Iuorno MJ and Nestler JE (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab90,1929\u20131935.","DOI":"10.1210\/jc.2004-1045"},{"key":"key\n\t\t\t\t20171012104259_AZZIZ-WOODS-2004","doi-asserted-by":"crossref","unstructured":"Azziz R , Woods KS, Reyna R, Key TJ, Knochenhauer ES and Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab89,2745\u20132749.","DOI":"10.1210\/jc.2003-032046"},{"key":"key\n\t\t\t\t20171012104259_CLAYTON-1992","doi-asserted-by":"crossref","unstructured":"Clayton RN , Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S and Meade TW (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf)37,127\u2013134.","DOI":"10.1111\/j.1365-2265.1992.tb02296.x"},{"key":"key\n\t\t\t\t20171012104259_CONWAY-1992","doi-asserted-by":"crossref","unstructured":"Conway GS , Agrawal R, Betteridge DJ and Jacobs, HS (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf)37,119\u2013125.","DOI":"10.1111\/j.1365-2265.1992.tb02295.x"},{"key":"key\n\t\t\t\t20171012104259_DEFRONZO-1979","doi-asserted-by":"crossref","unstructured":"DeFronzo RA , Tobin JD and Andres R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol237, E214\u2013E223.","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"key\n\t\t\t\t20171012104259_DEJAGER-2001","doi-asserted-by":"crossref","unstructured":"Dejager S , Pichard C, Giral P, Bruckert E, Federspield MC, Beucler I and Turpin G (2001) Smaller LDL particle size in women with polycystic ovary syndrome compared to controls. Clin Endocrinol (Oxf)54,455\u2013462.","DOI":"10.1046\/j.1365-2265.2001.01245.x"},{"key":"key\n\t\t\t\t20171012104259_DIAMANTI-KANDARAKIS-1995","doi-asserted-by":"crossref","unstructured":"Diamanti-Kandarakis E , Mitrakou A, Hennes, MM, Platanissiotis D, Kaklas N, Spina J, Georgiadou E, Hoffmann RG, Kissebah AH and Raptis S (1995) Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome. Metabolism44,525\u2013531.","DOI":"10.1016\/0026-0495(95)90062-4"},{"key":"key\n\t\t\t\t20171012104259_DUNAIF-1997","doi-asserted-by":"crossref","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev18,774\u2013800.","DOI":"10.1210\/er.18.6.774"},{"key":"key\n\t\t\t\t20171012104259_DUNAIF-SEGAL-1989","doi-asserted-by":"crossref","unstructured":"Dunaif A , Segal KR, Futterweit W and Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes38,1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20171012104259_EHRMANN-BARNES-1999","doi-asserted-by":"crossref","unstructured":"Ehrmann DA , Barnes RB, Rosenfield RL, Cavaghan MK and Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care22,141\u2013146.","DOI":"10.2337\/diacare.22.1.141"},{"key":"key\n\t\t\t\t20171012104259_GLUECK-2003","doi-asserted-by":"crossref","unstructured":"Glueck CJ , Papanna R, Wang P, Goldenberg N and Sieve-Smith L (2003) Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism52,908\u2013915.","DOI":"10.1016\/S0026-0495(03)00104-5"},{"key":"key\n\t\t\t\t20171012104259_KNOCHENHAUER-KEY-1998","doi-asserted-by":"crossref","unstructured":"Knochenhauer ES , Key TJ, Kahsar-Miller M, Waggoner W Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab83,3078\u20133082.","DOI":"10.1210\/jc.83.9.3078"},{"key":"key\n\t\t\t\t20171012104259_KORHONEN-2001","doi-asserted-by":"crossref","unstructured":"Korhonen S , Hippelainen M, Niskanen L, Vanhala M and Saarikoski S (2001) Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol184,289\u2013296.","DOI":"10.1067\/mob.2001.109596"},{"key":"key\n\t\t\t\t20171012104259_LEGRO-1999","doi-asserted-by":"crossref","unstructured":"Legro RS , Blanche P, Krauss RM and Lobo RA (1999) Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors. Fertil Steril72,990\u2013995.","DOI":"10.1016\/S0015-0282(99)00401-X"},{"key":"key\n\t\t\t\t20171012104259_LEGRO-KUNSELMAN-1999","doi-asserted-by":"crossref","unstructured":"Legro RS , Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women [see comments]. J Clin Endocrinol Metab84,165\u2013169.","DOI":"10.1097\/00006254-199906000-00019"},{"key":"key\n\t\t\t\t20171012104259_LEGRO-2001","doi-asserted-by":"crossref","unstructured":"Legro RS , Kunselman AR and Dunaif A (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med111,607\u2013613.","DOI":"10.1016\/S0002-9343(01)00948-2"},{"key":"key\n\t\t\t\t20171012104259_PIRWANY-2001","doi-asserted-by":"crossref","unstructured":"Pirwany IR , Fleming R, Greer IA, Packard CJ and Sattar N (2001) Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf)54,447\u2013453.","DOI":"10.1046\/j.1365-2265.2001.01228.x"},{"key":"key\n\t\t\t\t20171012104259_SAM-2003","doi-asserted-by":"crossref","unstructured":"Sam S and Dunaif A (2003) Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14,365\u2013370.","DOI":"10.1016\/j.tem.2003.08.002"},{"key":"key\n\t\t\t\t20171012104259_ST-ONGE-2004","doi-asserted-by":"crossref","unstructured":"St-Onge MP , Janssen I and Heymsfield SB (2004) Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care27,2222\u20132228.","DOI":"10.2337\/diacare.27.9.2222"},{"key":"key\n\t\t\t\t20171012104259_TALBOTT-1998","doi-asserted-by":"crossref","unstructured":"Talbott E , Clerici A, Berga, SL, Kuller L, Guzick D, Detre K, Daniels T and Engberg RA (1998) Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol51,415\u2013422.","DOI":"10.1016\/S0895-4356(98)00010-9"},{"key":"key\n\t\t\t\t20171012104259_TALBOTT-1995","doi-asserted-by":"crossref","unstructured":"Talbott E , Guzick D, Clerici A, Berga S, Detre K, Weimer K and Kuller L (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol15,821\u2013826.","DOI":"10.1161\/01.ATV.15.7.821"},{"key":"key\n\t\t\t\t20171012104259_TOPRAK-2001","doi-asserted-by":"crossref","unstructured":"Toprak S , Yonem A, Cakir B, Guler S, Azal O, Ozata M and Corakci A (2001) Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res55,65\u201370.","DOI":"10.1159\/000049972"},{"key":"key\n\t\t\t\t20171012104259_VRBIKOVA-2001","doi-asserted-by":"crossref","unstructured":"Vrbikova J , Hill M, Starka L, Cibula D, Bendlova B, Vondra K, Sulcova J and Snajderova M (2001) The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome. Eur J Endocrinol144,619\u2013628.","DOI":"10.1530\/eje.0.1440619"},{"key":"key\n\t\t\t\t20171012104259_VRBIKOVA-2004","doi-asserted-by":"crossref","unstructured":"Vrbikova J , Stanicka S, Dvorakova K, Hill M, Vondra K, Bendlova B and Starka L (2004) Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome. Eur J Endocrinol150,215\u2013223.","DOI":"10.1530\/eje.0.1500215"},{"key":"key\n\t\t\t\t20171012104259_WANG-2004","doi-asserted-by":"crossref","unstructured":"Wang JX and Norman RJ (2004) Risk factors for the deterioration of glucose metabolism in polycystic ovary syndrome. Reprod Biomed Online9,201\u2013204.","DOI":"10.1016\/S1472-6483(10)62130-X"},{"key":"key\n\t\t\t\t20171012104259_WILD-PAINTER-1985","doi-asserted-by":"crossref","unstructured":"Wild RA , Painter PC, Coulson PB, Carruth KB and Ranney GB (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab61,946\u2013951.","DOI":"10.1210\/jcem-61-5-946"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/12\/3328\/9542975\/dei221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T18:53:49Z","timestamp":1586372029000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/12\/3328\/2913646\/Metabolic-syndrome-in-young-Czech-women-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,5]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2005,8,5]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei221","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12]]},"published":{"date-parts":[[2005,8,5]]}}}